Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

NCT01737853 · clinicaltrials.gov ↗

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma Primary Open Angle

Interventions

DRUG: Ganforti
DRUG: Krytantek

Sponsor

Allergan S.A. DE C.V..